company background image
1701 logo

Cenra TWSE:1701 Stock Report

Last Price

NT$21.15

Market Cap

NT$6.0b

7D

0%

1Y

-8.8%

Updated

04 Sep, 2024

Data

Company Financials

1701 Stock Overview

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

1701 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Cenra Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cenra
Historical stock prices
Current Share PriceNT$21.15
52 Week HighNT$26.40
52 Week LowNT$20.20
Beta0
11 Month Change3.42%
3 Month Change-4.94%
1 Year Change-8.84%
33 Year Change-9.23%
5 Year Change13.40%
Change since IPO-38.58%

Recent News & Updates

Recent updates

China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50

Jul 12
China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50

Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

Apr 25
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

Apr 07
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

Mar 17
The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 24
China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Jan 27
Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

Jan 06
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

Dec 16
The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Nov 26
China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Shareholder Returns

1701TW PharmaceuticalsTW Market
7D0%-0.3%-2.4%
1Y-8.8%11.6%36.2%

Return vs Industry: 1701 underperformed the TW Pharmaceuticals industry which returned 14.7% over the past year.

Return vs Market: 1701 underperformed the TW Market which returned 30.6% over the past year.

Price Volatility

Is 1701's price volatile compared to industry and market?
1701 volatility
1701 Average Weekly Movement2.9%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.5%
10% most volatile stocks in TW Market8.8%
10% least volatile stocks in TW Market2.9%

Stable Share Price: 1701 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1701's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1952n/aChih-Yung Wuwww.ccpc.com.tw

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, health care products for the prevention of diseases and self-care, home care and cosmetics, and animal healthcare products. The company also research and development, contracting manufacturing and international business, sale and distribution of pharmaceutical brands, and senior care services.

Cenra Inc. Fundamentals Summary

How do Cenra's earnings and revenue compare to its market cap?
1701 fundamental statistics
Market capNT$6.01b
Earnings (TTM)NT$355.20m
Revenue (TTM)NT$8.87b

16.2x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1701 income statement (TTM)
RevenueNT$8.87b
Cost of RevenueNT$5.61b
Gross ProfitNT$3.26b
Other ExpensesNT$2.91b
EarningsNT$355.20m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.38
Gross Margin36.79%
Net Profit Margin4.00%
Debt/Equity Ratio36.9%

How did 1701 perform over the long term?

See historical performance and comparison